Key Highlights
- ARK Invest acquired 85,485 shares of Palantir valued at approximately $11.15M across its ETF portfolio
- The firm simultaneously offloaded 44,446 AMD shares valued at roughly $10.52M
- Palantir shares declined approximately 2% Friday following a sharp 7% drop Thursday
- Investor Michael Burry labeled Palantir’s valuation as entering “bubble” levels, pointing to Anthropic’s momentum
- Wedbush analyst Daniel Ives rejected Burry’s analysis, reaffirming his Buy stance with a $230 target price
Cathie Wood’s investment firm ARK Invest executed significant portfolio adjustments during April 10-11, 2026. The firm accumulated Palantir positions while trimming its Advanced Micro Devices holdings, based on ARK’s publicly disclosed trading activity.
The investment manager acquired 85,485 Palantir shares representing roughly $11.15 million in total value. Distribution across ARK’s portfolio included: ARKK with 46,455 shares, ARKQ receiving 15,127, ARKW adding 11,865, ARKF purchasing 5,973, and ARKX buying 6,065 shares.
Palantir Technologies Inc., PLTR
Concurrently, ARK divested 44,446 shares of Advanced Micro Devices, representing approximately $10.52 million in proceeds. These sales occurred proportionally across ARK’s five primary exchange-traded funds.
The strategic reallocation indicates ARK’s preference for AI-driven software solutions over semiconductor manufacturing exposure.
Market Headwinds Hit Palantir
Palantir’s stock experienced notable volatility during the week preceding ARK’s purchase. Shares declined around 2% Friday after suffering a substantial 7% retreat Thursday.
The downturn gained momentum following commentary from Michael Burry, the investor famous for anticipating the 2008 financial crisis. Burry published remarks on X suggesting Palantir’s current valuation has entered “bubble” range.
Burry’s thesis centered on competitive threats from Anthropic, highlighting the AI company’s “Mythos” platform and accelerating market expansion as potential disruptors to Palantir’s dominance. Wood capitalized on the weakness to increase exposure.
ARK additionally liquidated 75,389 shares of Strata Critical Medical worth $305,325, extending a pattern of reducing that holding throughout recent sessions.
Wall Street Remains Split
Burry’s cautionary stance hasn’t achieved universal acceptance. Daniel Ives from Wedbush Securities characterized Burry’s position as a “fictional narrative.”
Ives maintained his Buy recommendation on Palantir accompanied by a $230 price objective. He referenced Palantir’s impressive 137% expansion in U.S. Commercial segment revenue as validation of the company’s enduring competitive advantages.
Benchmark’s Yi Fu Lee adopts a more measured perspective. Lee contends that Palantir’s premium valuation requires flawless operational execution to support current price levels.
The broader analyst community consensus on Palantir registers as Moderate Buy. This rating reflects 14 Buy recommendations, 5 Hold positions, and 2 Sell ratings.
The mean analyst price projection following the recent turbulence stands at $194.61, implying approximately 52% potential appreciation from Friday’s market close.
Advanced Micro Devices stock climbed 3.55% on the identical trading session when ARK liquidated its stake.
